ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

ARMANDO HINOJOSA M.D.

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,648Medicare Part D Prescriptions Filled, Including Refills

Rank: 101 out of 2888

$1.09M Total Retail Price of All Prescriptions

Rank: 174 out of 2888

726 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

21% of this provider’s 726 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 15,241 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
METFORMIN HCL 908 666 1 8
ENALAPRIL MALEATE 716 607 2 49
SIMVASTATIN 697 605 3 2
ATORVASTATIN CALCIUM 630 514 4 9
OMEPRAZOLE 622 454 5 7
HYDROCODONE-ACETAMINOPHEN 600 360 S3 6 4
LEVOTHYROXINE SODIUM 596 509 7 1
AMLODIPINE BESYLATE 491 394 8 5
FUROSEMIDE 440 338 9 6
ALENDRONATE SODIUM 419 380 10 23
SERTRALINE HCL 355 276 11 27
IBUPROFEN 347 297 12 87
GLIPIZIDE 337 259 13 50
LOSARTAN POTASSIUM 326 280 14 18
NEXIUM 313 252 15 19
ZOLPIDEM TARTRATE 290 197 16 17
JANUVIA 277 181 17 48
HYDROCHLOROTHIAZIDE 270 247 18 15
METOPROLOL TARTRATE 252 213 19 10
TRAMADOL HCL 234 185 20 16
DIOVAN 225 174 21 35
CLOPIDOGREL 212 169 22 30
GLIMEPIRIDE 207 158 23 36
ACTOS 199 147 24 108
MELOXICAM 182 141 25 31
LOSARTAN-HYDROCHLOROTHIAZIDE 182 156 25 46
AZITHROMYCIN 172 141 27 38
ENALAPRIL-HYDROCHLOROTHIAZIDE 168 128 28 315
LISINOPRIL 167 146 29 3
GABAPENTIN 165 129 30 13
PLAVIX 164 150 31 40
LYRICA 160 87 32 69
VERAPAMIL ER 157 118 33 104
CLONIDINE HCL 157 83 33 39
POTASSIUM CHLORIDE 154 127 35 14
DONEPEZIL HCL 149 149 36 26
LEVOFLOXACIN 145 113 37 57
CLOTRIMAZOLE-BETAMETHASONE 138 90 38 136
GLYBURIDE 135 107 R 39 58
LIPITOR 131 99 40 78
DIGOXIN 125 100 41 55
PRAVASTATIN SODIUM 114 94 42 12
TAMSULOSIN HCL 113 87 43 29
AVODART 112 97 44 151
CIPROFLOXACIN HCL 111 90 45 47
MECLIZINE HCL 109 106 46 122
BENAZEPRIL HCL 106 91 47 77
CITALOPRAM HBR 102 71 48 24
TRAMADOL HCL-ACETAMINOPHEN 102 97 48 95
OXYBUTYNIN CHLORIDE 97 86 50 124
NOVOLIN 70-30 94 83 51 144
ESCITALOPRAM OXALATE 93 83 52 62
CYMBALTA 91 48 53 44
INSULIN SYRINGE 89 68 54 86
MEGESTROL ACETATE 88 84 R 55 140
DIOVAN HCT 87 67 56 61
CARVEDILOL 87 56 56 21
POLYETHYLENE GLYCOL 3350 85 76 58 93
METOPROLOL SUCCINATE 85 59 58 11
NAPROXEN 84 66 60 80
FINASTERIDE 83 83 61 102
ATENOLOL 81 63 62 25
LANTUS 80 62 63 45
NIFEDIPINE ER 78 48 64 76
CRESTOR 76 57 65 20
CILOSTAZOL 72 58 66 165
PIOGLITAZONE HCL 70 57 R 67 248
PANTOPRAZOLE SODIUM 68 55 68 33
METOCLOPRAMIDE HCL 68 31 68 116
VOLTAREN 68 56 68 157
METHOCARBAMOL 66 49 R 71 176
DICLOFENAC SODIUM 64 62 72 141
ZETIA 60 57 73 81
ACTONEL 60 49 73 149
RAMIPRIL 59 53 75 73
PREDNISONE 59 45 75 42
RANITIDINE HCL 58 34 77 56
ALLOPURINOL 55 21 78 37
PHENYTOIN SODIUM EXTENDED 55 15 78 128
NOVOLIN N 54 54 80 255
ISOSORBIDE MONONITRATE ER 54 54 80 51
HYDROCODONE BIT-IBUPROFEN 53 36 S3 82 280
SINGULAIR 53 35 82 85
LACTULOSE 51 35 84 111
NIFEDICAL XL 51 42 84 190
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.